Lactoferrin and angiogenin compositions and uses thereof

1. A composition comprising isolated lactoferrin (LF) and isolated angiogenin (AGN) in a LF:AGN wt/wt ratio of from 50:1 to 9:1, wherein the concentration of LF is 10-25 wt % and wherein the concentration of AGN is 0.5-10 wt % in the composition and wherein the LF is complexed to a metal selected from the group consisting of zinc, copper, manganese, chromium, aluminum and gallium.

2. The composition of claim 1 , wherein the lactoferrin is combined with an anionic compound selected from the group consisting of a carbonate, a bicarbonate, and a carbonated liquid.

3. The composition of claim 2 , wherein the anionic compound is a bicarbonate.

4. The composition of claim 1 , wherein the LF is complexed to copper.

5. The composition of claim 1 , wherein the ratio of LF : AGN ranges between 20:1 to 9:1.

6. The composition of claim 1 , further comprising an oil, a suspending agent, a flavoring agent, coloring agents or combinations thereof.

7. The composition of claim 6 , wherein the oil is one or more selected from the group consisting of seed oil, fish or marine oil, canola oil, vegetable oil, safflower oil, sunflower oil, nasturtium seed oil, mustard seed oil, olive oil, sesame oil, soybean oil, corn oil, peanut oil, cottonseed oil, rice bran oil, palm oil, rapeseed oil, palm kernel oil, lupin oil, coconut oil, flaxseed oil, and evening primrose oil.

8. The composition of claim 1 , further comprising a compound selected from the group consisting of phospholipids, antioxidants, vitamins, amino acids, proteins, essential minerals, lecithin and combinations thereof.

9. The composition of claim 8 , wherein the composition further comprises L-carnitine, acetyl-L-carnitine or propionyl L-carnitine in an amount of 1% to 50% by weight.

10. The composition of claim 8 , wherein the phospholipid is one or more selected from the group consisting of Docosahexaenoic acid (DHA), phosphatidyl glycerol, phosphatidyl inositol, phosphatidyl serine, phosphatidyl choline, phosphatidyl ethanolamine, phosphatidic acids, ceramides, cerebrosides, sphingomyelins and cardiolipins.

11. The composition of claim 8 , wherein the vitamin is one or more selected from the group consisting of vitamin A, thiamine, niacinamide, pyridoxine, riboflavin, cyanocobalamin, biotin, pantothenic acid, vitamin C, vitamin D, vitamin E, vitamin K and folic acid.

12. The composition of claim 8 , wherein the mineral is one or more selected from the group consisting of iron, calcium, magnesium, sodium, potassium, copper, chromium, zinc, molybdenum, iodine, boron, selenium, manganese, and combinations thereof.

13. The composition of claim 8 , wherein lecithin is present in an amount of 10% to 60% by weight.

14. The composition of claim 1 , further comprising a viable or a non-viable probiotic selected from the group consisting of L. acidophilus, L. amylovorus, L. animalis, L. bavaricus, L. brevis, L. bulgaricus, L. casei spp. casei, L. casei spp. rhamnosus, L. crispatus, L. delbrueckii ssp. lactis, L. eichmanni, L. fermentum, L. helveticus, L. jensenii, L. kefir, L. paracasei, L. pentosus, L. plantarum, L. reuteri, L. sahvarius, L. sake, Leu. cremoris, Leu. lactis; B. adolescentis, B. animalis, B. bifidum, B. breve, B. infantis, B. longum , and B. thermophilum; Ped. acidilactici, Ped. pentosus, Pep. assacharolyticus, Pep. productus; Pro. acidipropionici, Pro. freudenreichii, Pro. jensenii, Pro. theonii, Strep. cremoris, Strep. faecium, Strep. lactis, Strep. raffinolactis and Strep. thermophilus.

15. A formulation comprising the composition of claim 1 , wherein the formulation further comprises S-adenosylmethionine.

16. A formulation comprising the composition of claim 1 , wherein the formulation further comprises, at least two of the following ingredients: chondroitin sulfate, glucosamine sulfate, methylsulfonylmethane, dimethylglycine, or cerasomal-cis-9-cetylmyristoleate.

17. A carbonated beverage comprising the composition of claim 1 .

18. A composition according to claim 1 , wherein said isolated lactoferrin and isolated angiogenin are obtained from a LF:AGN premix prepared by a method comprising:

isolating a LF-enriched fraction from a dairy, a non-dairy or a recombinant source;

isolating an AGN-enriched fraction from a dairy, a non-dairy or a recombinant source;

combining the LF-enriched fraction with the AGN-enriched fraction;

freeze-drying or spray-drying the combined fractions; and

milling the freeze-dried or spray-dried combined fractions to obtain a LF:AGN premix.

19. The composition of claim 1 , wherein the LF is complexed to zinc.